Crossmark

Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study

Crossref DOI link: https://doi.org/10.1186/s13229-018-0253-1

Published Online: 2019-01-09

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Long, Manhai https://orcid.org/0000-0002-4517-1829
Ghisari, Mandana

Kjeldsen, Lisbeth

Wielsøe, Maria

Nørgaard-Pedersen, Bent

Mortensen, Erik Lykke

Abdallah, Morsi W.

Bonefeld-Jørgensen, Eva C.
Funding

Funding for this research was provided by:

Aarhus Universitet (4414-11405)

Statens Serum Institute (271-05-0523/09-060179)

Danish Research and Innovation Council (271-07-0385)
License Information

Text and Data Mining valid from 2019-01-09
More Information

Article History

Received: 18 October 2017

Accepted: 7 December 2018

First Online: 9 January 2019

Ethics approval and consent to participate

: The study was approved by the Steering Committee for Scientific Use of the Newborn Screening Biobank and the Danish Data Protection Agency (Record No. 2009-41-3173) as well as the Central Denmark Region Ethics Committee on Health Research (Record No. M-20090066). Since all data were obtained retrospectively in an anonymized manner, there was no need to obtain consent from any of the participants.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.